» Articles » PMID: 29969525

MicroRNA MiR-223 As Regulator of Innate Immunity

Overview
Journal J Leukoc Biol
Date 2018 Jul 4
PMID 29969525
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs were discovered more than 2 decades ago and have profound impact on diverse biological processes. Specific microRNAs have important roles in modulating the innate immune response and their dysregulation has been demonstrated to contribute to inflammatory diseases. MiR-223 in particular, is very highly expressed and tightly regulated in hematopoietic cells. It functions as key modulator for the differentiation and activation of myeloid cells. The central role of miR-223 in myeloid cells, especially neutrophil and macrophage differentiation and activation has been studied extensively. MiR-223 contributes to myeloid differentiation by enhancing granulopoiesis while inhibiting macrophage differentiation. Uncontrolled myeloid activation has detrimental consequences in inflammatory disease. MiR-223 serves as a negative feedback mechanism controlling excessive innate immune responses in the maintenance of myeloid cell homeostasis. This review summarizes several topics covering the function of miR-223 in myeloid differentiation, neutrophil and macrophage functions, as well as in inflammatory diseases including acute respiratory distress syndrome and inflammatory bowel disease. In addition, nonmyeloid functions of miR-223 are also discussed in this review. Therapeutic enhancement of miR-223 to dampen inflammatory targets is also highlighted as potential treatment to control excessive innate immune responses during mucosal inflammation.

Citing Articles

The functions of immune system-derived miRNAs in cardiovascular diseases.

Sufianov A, Agaverdiev M, Mashkin A, Ilyasova T Noncoding RNA Res. 2024; 11:91-103.

PMID: 39736852 PMC: 11683256. DOI: 10.1016/j.ncrna.2024.11.004.


Non-Coding RNAs and Innate Immune Responses in Cancer.

Diaz C, Hernandez-Huerta M, Perez-Campos Mayoral L, Villegas M, Zenteno E, Martinez Cruz M Biomedicines. 2024; 12(9).

PMID: 39335585 PMC: 11429077. DOI: 10.3390/biomedicines12092072.


MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces.

Barbagallo D, Ponti D, Bassani B, Bruno A, Pulze L, Akkihal S Int J Mol Sci. 2024; 25(15).

PMID: 39125761 PMC: 11311375. DOI: 10.3390/ijms25158191.


A Review of Key Regulators of Steady-State and Ineffective Erythropoiesis.

Tichil I, Mitre I, Zdrenghea M, Bojan A, Tomuleasa C, Cenariu D J Clin Med. 2024; 13(9).

PMID: 38731114 PMC: 11084473. DOI: 10.3390/jcm13092585.


Role of miRNAs in neurovascular injury and repair.

Sawant H, Sun B, Mcgrady E, Bihl J J Cereb Blood Flow Metab. 2024; 44(10):1693-1708.

PMID: 38726895 PMC: 11494855. DOI: 10.1177/0271678X241254772.


References
1.
Reinhart B, Slack F, Basson M, Pasquinelli A, Bettinger J, Rougvie A . The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000; 403(6772):901-6. DOI: 10.1038/35002607. View

2.
Zamore P, Tuschl T, Sharp P, Bartel D . RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell. 2000; 101(1):25-33. DOI: 10.1016/S0092-8674(00)80620-0. View

3.
Pasquinelli A, Reinhart B, Slack F, Martindale M, Kuroda M, Maller B . Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature. 2000; 408(6808):86-9. DOI: 10.1038/35040556. View

4.
Lai E . Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet. 2002; 30(4):363-4. DOI: 10.1038/ng865. View

5.
Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View